You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

408 Results
Document
Nov 2020
Guidelines and Advice
Status: Current
ID: PET 2020-1
Version: N/A
Nov 2020
Guidelines and Advice
Status: Current
Version: 1.0
Dec 1969
Guidelines and Advice
Status: Current
ID: ES 11-13
Dec 1969
Regimen
Cancer Type:
Skin, 
Basal Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Drugs Used:
sonidegib (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Statistical Reports
Dec 1969
Statistical Reports
Jan 2018
Guidelines and Advice
Status: Current
Dec 1969
Guidelines and Advice
Status: Current
Dec 1969
Guidelines and Advice
Status: Current
ID: PET 2020-2
Dec 1969
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    selpercatinib - For the treatment of metastatic RET fusion-positive non-small cell lung cancer (NSCLC)
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
selpercatinib
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Il vous est demandé, au travers des questions posées dans l’enquête Votre opinion est importante, d’exprimer votre ressenti quant à votre plus récent...

Pages